THE LUNG TRANSPLANT FOUNDATION (EIN 262484253) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

HARRY COLLINS

Phone

9198657000

Tax Period

2023-10-01 to 2024-09-30

THE LUNG TRANSPLANT FOUNDATION, founded in 2009, is a small nonprofit in the Diseases & Disorders sector that reported $268K in total revenue in fiscal year 2023. Revenue surged 120% from the prior year, signaling strong growth momentum. The organization ran a surplus of $49K, a strong 18% operating margin.

Mission

LTF HAS CONTINUED TO EXPAND OUR WORK WITH ADDITIONAL EDUCATIONAL PROGRAMMING, PEER TO PEER MENTORSHIP, PATIENT SUPPORT, PARTNERSHIPS, AND AMPLIFYING THE PATIENT VOICE IN LUNG TRANSPLANT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $157,817

Program Service Revenue $0

Investment Income $110,185

Other Revenue $0

TOTAL REVENUE $268,002

Expense Breakdown

Grants Paid $0

Salaries & Benefits $136,133

Fundraising Expenses $16,119

Program Expenses $163,295

Other Expenses $82,381

TOTAL EXPENSES $218,514

Year-over-Year Comparison

	2023	2022	Change
Revenue	$268,002	$121,973	+1.2%
Expenses	$218,514	$232,260	-0.1%
Net Income	$49,488	$-110,287	-1.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$123,869

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
HARRY COLLINS	PRESIDENT	8.00	Officer Director	$0	$0	$0
TIM BERGER	DIRECTOR	8.00	Director	$0	$0	$0
ELLEN GOLDSTEIN	SECRETARY	25.00	Officer Director	$0	$0	$0
BRIAN BENNETT	TREASURER	1.00	Officer Director	$0	$0	$0
PAUL SUN	DIRECTOR	0.50	Director	$0	$0	$0
KELLY DAGGER	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
JONATHAN REISS	EX COMMITTEE	4.00	Director	$0	$0	$0
JOHN REYNOLD	DIRECTOR	2.00	Director	$0	$0	$0
ELIA COLLINS	DIRECTOR	0.50	Director	$0	$0	$0
LINDA WALSH	DIRECTOR	1.00	Director	$0	$0	$0
JANICE SUTTON	DIRECTOR	0.50	Director	$0	$0	$0
AMY SKIBA	EXECUTIVE DIRECTOR	40.00	Officer	$123,869	$0	$123,869

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$268,002	$218,514	$195,420	$49,488
2021	$359,240	$135,760	$352,187	$223,480

THE LUNG TRANSPLANT FOUNDATION